Notably, our findings that COX-2 expression depends on active RAF/MEK signaling suggests that reduced production of PGE2 by melanoma cells may contribute to the immune-dependent anti-cancer activity elicited by BRAF inhibitors (Frederick et al., 2013; Knight et al., 2013). This evidence concerns the gene PTGS2 and melanoma.